1. Home
  2. MAIA vs BMR Comparison

MAIA vs BMR Comparison

Compare MAIA & BMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIA
  • BMR
  • Stock Information
  • Founded
  • MAIA 2018
  • BMR 2009
  • Country
  • MAIA United States
  • BMR Israel
  • Employees
  • MAIA N/A
  • BMR N/A
  • Industry
  • MAIA Biotechnology: Pharmaceutical Preparations
  • BMR Computer Software: Prepackaged Software
  • Sector
  • MAIA Health Care
  • BMR Technology
  • Exchange
  • MAIA Nasdaq
  • BMR Nasdaq
  • Market Cap
  • MAIA 56.3M
  • BMR 47.4M
  • IPO Year
  • MAIA 2022
  • BMR 2023
  • Fundamental
  • Price
  • MAIA $1.84
  • BMR $3.02
  • Analyst Decision
  • MAIA
  • BMR
  • Analyst Count
  • MAIA 0
  • BMR 0
  • Target Price
  • MAIA N/A
  • BMR N/A
  • AVG Volume (30 Days)
  • MAIA 636.1K
  • BMR 199.4K
  • Earning Date
  • MAIA 11-11-2025
  • BMR 08-13-2025
  • Dividend Yield
  • MAIA N/A
  • BMR N/A
  • EPS Growth
  • MAIA N/A
  • BMR N/A
  • EPS
  • MAIA N/A
  • BMR N/A
  • Revenue
  • MAIA N/A
  • BMR $3,131,000.00
  • Revenue This Year
  • MAIA N/A
  • BMR $21.21
  • Revenue Next Year
  • MAIA N/A
  • BMR N/A
  • P/E Ratio
  • MAIA N/A
  • BMR N/A
  • Revenue Growth
  • MAIA N/A
  • BMR 5.96
  • 52 Week Low
  • MAIA $1.40
  • BMR $1.86
  • 52 Week High
  • MAIA $3.48
  • BMR $6.59
  • Technical
  • Relative Strength Index (RSI)
  • MAIA 64.38
  • BMR 50.88
  • Support Level
  • MAIA $1.65
  • BMR $2.97
  • Resistance Level
  • MAIA $1.88
  • BMR $3.24
  • Average True Range (ATR)
  • MAIA 0.09
  • BMR 0.14
  • MACD
  • MAIA 0.03
  • BMR 0.02
  • Stochastic Oscillator
  • MAIA 73.33
  • BMR 50.00

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

About BMR Beamr Imaging Ltd.

Beamr Imaging Ltd is a video technology and image science software company. It is an innovator of video encoding, transcoding, and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for video and images. The company is conducted through one operating segment, the optimization technology for video and photo compression. The company operates in Israel, the United States, and the rest of the world, it derives a majority of its revenue from the United States.

Share on Social Networks: